Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03558828 · ClinicalTrials.gov registry record · NA

Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women

A NA study of Physical Activity, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
301
Enrollment target
1
Study location

NCT03558828: Completed NA study of Physical Activity, sponsored by Rush University Medical Center.

NCT03558828 is a NA study of Physical Activity that has completed, run by Rush University Medical Center. The registered enrollment target is 301 participants, below the 356-participant average among 131 other Physical Activity trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03558828, a NA study of Physical Activity, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
301 participants
Enrollment target
1
Study location

Study Summary

This study employs a Sequential Multiple Assignment Randomized Trial (SMART) and aims to determine the most effective adaptive intervention combining four efficacious treatments (enhanced physical activity monitor, motivational text messages, motivational personal calls, group meetings) to increase physical activity and improve cardiovascular health among sedentary employed women.

Primary Outcome

Physical activity-Steps: Average daily steps were measured with ActiGraph worn on the right hip during waking hours for one week.

Conditions Studied

Interventions

  • BEHAVIORAL Step 1: PA Monitor
  • BEHAVIORAL Step 1: PA Monitor + Text
  • BEHAVIORAL Step 2: PA Monitor with Calls
  • BEHAVIORAL Step 2: PA Monitor with Meetings
  • BEHAVIORAL Step 2: PA Monitor + Texts with Calls

Study Locations (1)

Illinois

  • Rush University College of Nursing - Chicago

Trial Details

FieldValue
Enrollment Target 301 participants
Start Date 2018-08-24
Est. Completion 2025-06-30
Phase NA
Rush University Medical Center

320 total trials

What the finished NCT03558828 record still lists

NCT03558828 is an interventional study that assigns participants to a tested intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap, below the 356-participant average among 131 other Physical Activity trials with a reported enrollment target (15% lower).

The record links to 1 condition, with Physical Activity appearing as the primary indexed condition, and to 5 interventions - of which Step 1: PA Monitor is the first listed.

NCT03558828 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03558828 about?

NCT03558828 is a clinical study titled "Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women". This study employs a Sequential Multiple Assignment Randomized Trial (SMART) and aims to determine the most effective adaptive intervention combining four efficacious treatments (enhanced physical activity monitor, motivational text messages, motivational personal calls, group meetings) to increase ...

What is the current status of trial NCT03558828?

This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2018-08-24. Estimated completion is 2025-06-30.

What conditions does trial NCT03558828 study?

This clinical trial studies the following conditions: Physical Activity.

What interventions are being tested in trial NCT03558828?

The interventions under investigation include: Step 1: PA Monitor (BEHAVIORAL), Step 1: PA Monitor + Text (BEHAVIORAL), Step 2: PA Monitor with Calls (BEHAVIORAL), Step 2: PA Monitor with Meetings (BEHAVIORAL), Step 2: PA Monitor + Texts with Calls (BEHAVIORAL).

Who is sponsoring clinical trial NCT03558828?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03558828 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03558828's enrollment target sits among peer trials

301 37th of 131 higher than 95 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05005975 · 301 participants · Phase 3

    Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

  • NCT05722561 · 302 participants · Phase 2

    E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

  • NCT06015737 · 302 participants · Phase 3

    A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

  • NCT07176273 · 302 participants · NA

    Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03558828, the US trial registry maintained by the National Library of Medicine. NCT03558828 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.